HF
AXDX

HRT Financial’s Accelerate Diagnostics AXDX Stock Holding History

HRT Financial’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,293
Closed -$9K – 2481
2022
Q4 		$9K Buy
+1,293
New +$14.1K ﹤0.01% 2229
2022
Q3 		– Sell
-11,559
Closed -$114K – 2787
2022
Q2 		$114K Buy
11,559
+8,772
+315% +$77.5K ﹤0.01% 2401
2022
Q1 		$40K Buy
2,787
+689
+33% +$19.6K ﹤0.01% 2766
2021
Q4 		$109K Buy
2,098
+77
+4% +$4.29K ﹤0.01% 2740
2021
Q3 		$117K Buy
+2,021
New +$132K ﹤0.01% 2855
2021
Q2 		– Sell
-1,227
Closed -$102K – 2833
2021
Q1 		$102K Sell
1,227
-618
-33% -$62.7K ﹤0.01% 2459
2020
Q4 		$139K Buy
+1,845
New +$165K ﹤0.01% 1582

Other funds holding AXDX

GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return

HRT Financial's AXDX Position: Q1 2023 in Review

HRT Financial sold out of Accelerate Diagnostics (AXDX) in Q1 2023, closing a stake of 1,293 shares — an estimated $9K sold.

HRT Financial first reported a position in AXDX in Q4 2020 and held it in 7 quarters. The position peaked at $139K in Q4 2020. 66 funds tracked by Wall St. Rank hold AXDX as of Q1 2023.

  • HRT Financial reported no remaining Accelerate Diagnostics position as of Q1 2023 after selling out during the quarter.
  • HRT Financial sold 1,293 Accelerate Diagnostics shares in Q1 2023, an estimated $9K.
  • HRT Financial first reported a position in Accelerate Diagnostics in Q4 2020 and held it in 7 quarters.
  • HRT Financial's Accelerate Diagnostics position peaked at $139K in Q4 2020.
  • 66 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2023.

Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.